Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.

MLA

Xie, Xiao-Hong, et al. “Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.” Frontiers in Oncology, vol. 11, June 2021, p. 673877. EBSCOhost, https://doi.org/10.3389/fonc.2021.673877.

APA

Xie, X.-H., Deng, H.-Y., Lin, X.-Q., Wu, J.-H., Liu, M., Xie, Z.-H., Qin, Y.-Y., & Zhou, C.-Z. (2021). Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer. Frontiers in Oncology, 11, 673877. https://doi.org/10.3389/fonc.2021.673877

Chicago

Xie, Xiao-Hong, Hai-Yi Deng, Xin-Qing Lin, Jian-Hui Wu, Ming Liu, Zhan-Hong Xie, Yin-Yin Qin, and Cheng-Zhi Zhou. 2021. “Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.” Frontiers in Oncology 11 (June): 673877. doi:10.3389/fonc.2021.673877.